UroGen Pharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell UroGen Pharma and other ETFs, options, and stocks.About URGN
UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology.
URGN Key Statistics
Stock Snapshot
The current UroGen Pharma(URGN) stock price is $25.73, with a market capitalization of 1.26B. The stock trades at a price-to-earnings (P/E) ratio of -14.41.
On 2026-11-05, UroGen Pharma(URGN) stock moved within a range of $25.07 to $29.04. With shares now at $25.73, the stock is trading +2.6% above its intraday low and -11.4% below the session's peak.
Trading activity shows a volume of 2.43M, compared to an average daily volume of 1.52M.
The stock's 52-week range extends from a low of $16.50 to a high of $50.81.
The stock's 52-week range extends from a low of $16.50 to a high of $50.81.
URGN News
...
Some cancers announce themselves with drama. Low-grade bladder cancer does the opposite. It is usually slow-growing and rarely life-threatening, which is the go...
UroGen Pharma reported that the first patient has now been dosed in its Phase 1, open-label, dose-escalation trial of UGN-501 for adults with recurrent non-musc...
Analyst ratings
100%
of 7 ratingsMore URGN News
UroGen Pharma (URGN) is back in focus after publishing final five-year Olympus follow-up data on JELMYTO, highlighting durable responses in low-grade upper trac...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.